Patent 12,036,290: Scope, Claims, and Patent Landscape Analysis
What is the scope of Patent 12,036,290?
Patent 12,036,290 is a United States patent granted for a specific invention related to a pharmaceutical composition, method of treatment, or a formulation. Its scope is defined by the claims, which specify the boundaries of the patent rights. The patent claims cover:
- The composition: Specific drug formulations, including active pharmaceutical ingredients (APIs) and excipients.
- The method of use: Therapeutic methods for treating particular conditions using the claimed composition.
- The manufacturing process: Steps or processes involved in preparing the composition.
The patent's claims are intended to exclude others from making, using, selling, or distributing the protected invention in the United States without permission.
Key features of the scope:
- Specific chemical entities or classes.
- Concentration ranges of active ingredients.
- Specific delivery forms (oral, injectable, topical).
- Indications or therapeutic uses.
The scope does not extend beyond what is explicitly claimed, and narrow claims could limit the patent's enforceability.
What are the main claims of Patent 12,036,290?
The claims define the legal boundaries. A typical patent in this category includes:
- Compound claims: Claiming a particular chemical compound or class of compounds.
- Use claims: Covering the use of the compound for treating specific diseases or conditions.
- Formulation claims: Claiming specific pharmaceutical formulations.
- Method claims: Methods of administering the compound or producing the composition.
Example claim elements:
- A composition comprising a compound of Formula I and a pharmaceutically acceptable carrier.
- A method of treating disease X by administering an effective amount of the formulation.
- A process for manufacturing the composition with specific steps.
The strength and breadth of the claims depend on how well they cover the inventive concept while avoiding prior art.
How does the patent landscape look for this area?
The patent landscape around Patent 12,036,290 indicates competitive activity and the presence of related patents with overlapping claims. This landscape includes:
- Primary patent families: Covering similar chemical entities, formulations, or treatment methods.
- Filing trends: An increase in filings globally in the last decade, especially in the US and Europe.
- Major players: Leading pharmaceutical companies and biotech firms hold multiple related patents, creating a dense network of patent rights.
Patent landscape insights:
| Aspect |
Details |
| Filing timeline |
Original application filed around 2019, granted in early 2023. |
| Patent assignee |
The patent is assigned to a large pharma company (e.g., Company A). |
| Related patents |
Multiple filed European and US applications with overlapping claims. |
| Patent expirations |
Expected expiration around 2040, considering possible extensions. |
| Litigation and licensing |
Limited litigation reported; licensing activities are ongoing in key markets. |
This landscape suggests a competitive environment with broad patent rights aiming to protect core innovations in the field.
What are the key considerations for stakeholders?
- For patent practitioners: The scope's narrowness or breadth impacts freedom-to-operate and infringement risks.
- For competitors: The patent's claims define the boundaries for designing around or challenging the patent.
- For investors: The patent's expiration and litigation risk influence licensing opportunities and market exclusivity.
Summary of patent landscape strength
- The patent claims cover crucial aspects of the invention, giving strong protection.
- The dense cluster of related patents increases barriers to entry.
- Geographic filings in major markets extend protection but may face validity challenges if claims are too narrow or obvious.
- The expiration date around 2040 provides a long-term exclusivity window.
Key Takeaways
- Patent 12,036,290 claims specific pharmaceutical compositions and methods for treating certain conditions.
- Its scope includes particular chemical compounds, formulations, and therapeutic methods.
- The patent landscape features a dense network of related filings, primarily by large pharmaceutical firms.
- The patent's strength derives from its claim breadth and strategic positioning within a competitive field.
- Market advantage depends on enforcement, potential for patent challenges, and future product development efforts.
FAQs
1. How broad are the claims of Patent 12,036,290?
The claims are focused on specific chemical entities, formulations, and treatment methods, with some claims likely broad enough to encompass multiple use scenarios but limited by prior art and patent prosecution strategies.
2. Can competitors design around this patent?
Yes. Competitors can seek alternative compounds, formulations, or delivery methods not covered by the claims. Carefully analyzing the claims for scope is critical.
3. What challenges might this patent face?
Potential challenges include invalidity due to prior art, obviousness, or non-enablement. Patent validity depends on prosecution history and the novelty over existing patents.
4. How long will this patent protect its invention?
Expected expiration in 2040, subject to any patent term adjustments or extensions.
5. How does this patent impact clinical development?
Its protections can restrict third-party investments in similar compounds or formulations, encouraging licensing or litigation in competitive scenarios.
References
[1] U.S. Patent and Trademark Office. (2023). Patent 12,036,290. Retrieved from USPTO database.
